ReviewPharmacoEconomics1999
Recent advances in the methods of cost-benefit analysis in healthcare. Matching the art to the science.
Review in PharmacoEconomics, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- A systematic review of stated preference studies reporting public preferences for healthcare priority setting.The patient · 2014Pooled it
- Economic analysis of the health impacts of housing improvement studies: a systematic review.Journal of epidemiology and community health · 2013Pooled it
- Is next generation sequencing for the diagnosis of rare diseases worth its cost? A user-based approach to valuation.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
- [Current status and progress of health economics research on allergen specific immunotherapy].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025Review
- Optimizing the Implementation of Clinical Predictive Models to Minimize National Costs: Sepsis Case Study.Journal of medical Internet research · 2023Article
- Cost-effectiveness of chronic hepatitis C screening and treatment.Clinical and molecular hepatology · 2022Review
- Impacts from Economic Development and Environmental Factors on Life Expectancy: A Comparative Study Based on Data from Both Developed and Developing Countries from 2004 to 2016.International journal of environmental research and public health · 2021Article
- A framework for making predictive models useful in practice.Journal of the American Medical Informatics Association : JAMIA · 2021Article
- The business case for quality improvement.Journal of perinatology : official journal of the California Perinatal Association · 2020Article
- Dementia and Imagination: A Social Return on Investment Analysis Framework for Art Activities for People Living With Dementia.The Gerontologist · 2020Article
- Projecting the impact of a nationwide school plain water access intervention on childhood obesity: a cost-benefit analysis.Pediatric obesity · 2018Article
- Assessing value-for-money in maternal and newborn health.BMJ global health · 2017Review
- Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics.PharmacoEconomics · 2016Article
- An exploration of parents' preferences for foot care in juvenile idiopathic arthritis: a possible role for the discrete choice experiment.Journal of foot and ankle research · 2014Article
- Mapping ASTI patient's therapeutic-data model to virtual Medical Record: can VMR represent therapeutic data elements used by ASTI in clinical guideline implementations?AMIA ... Annual Symposium proceedings. AMIA Symposium · 2013Article
- Viewpoint: Economic evaluation of package of care interventions employing clinical guidelines.Tropical medicine & international health : TM & IH · 2011Article
- Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods.PharmacoEconomics · 2007Article
- The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2006Article
- Using discrete choice experiments within a cost-benefit analysis framework: some considerations.PharmacoEconomics · 2006Article
- Willingness to pay to assess patient preferences for therapy in a Canadian setting.BMC health services research · 2005Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper outlines recent advances in the methods of cost-benefit analysis (CBA). Economic evaluations in healthcare can be criticised for, amongst other things, the inappropriate use of incremental cost-effectiveness ratios and the reporting of benefits in terms of cost savings, such as treatment costs averted. Many such economic evaluations are, according to the 'scientific' definition, CBAs. The 'balance-sheet' (or opportunity cost) approach is a form of CBA which can be used to identify who bears the costs and who reaps the benefits from any change. Whilst the next stage in a CBA, as defined in health economics, would require that all costs and benefits be valued in monetary terms, the balance-sheet approach, however, advocates that available monetary values can be augmented by other measures of cost and benefit. As such, this approach, which has a theoretical basis, is proposed as a practical prescription for CBA and highlights the notion that unquantified benefits are important and can be included within CBAs even when monetarisation is not possible. Recent methodological developments in monetary valuation for use in CBA are the development of the technique of willingness to pay, the use of conjoint analysis (CA) to elicit willingness-to-pay (WTP) values and advances in the debate on the inclusion of production gains in CBAs. Whilst acknowledging that there have been developments in each of these areas, it is claimed there has also been progress in using CBA as a framework for evaluation, as reflected by the balance-sheet approach. The paper concludes by stating that almost all types of economic evaluation have an element of the 'cost-benefit' approach in them. The important issue is to focus on the policy question to be addressed and to outline the relevant costs and benefits in a manner which assists the evaluation of welfare changes resulting from changes in healthcare delivery. The focus should not be on moulding a question to fit a hybrid definition of an analytical technique.
Indexed as
Identifiers
10537954What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.